Cellular Bioengineering Inc. (CBI) is a sister company to SKAI Ventures and is a Hawaii-based accelerator of disruptive technologies with biomedical applications. CBI searches for innovative and ingenious ideas which it can nurture and grow into mature products that will change the way the world operates. Cellular Bioengineering Inc. is home to EYEGENIX Artificial Cornea. There are currently 10 million people worldwide with corneal blindness due to the lack of adequate organ donors. CBI has the worldwide license for the development of a bio-integrating polymer corneal substitute which aims to return the gift of sight to these people. Currently in pilot clinical trials, the initial cohort of patients shows promising results at preliminary followup.